Metabolomic profiling for selection of the most viable embryos in clinical IVF

Current Women's Health Reviews

Volumn 6, Issue 3, 2010, Pages 254-260

  Thouas, George A ^a   Gardner, David K ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Implantation rate; Metabolomics; Pregnancy; Preimplantation embryo; Viability

Indexed keywords

PROTEOME;

ARTICLE; BIOINFORMATICS; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FETUS DEVELOPMENT; HUMAN; IN VITRO SELECTION; METABOLOMICS; MICROFLUOROMETRY; NIDATION; NONHUMAN; PREGNANCY OUTCOME; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL;

EID: 78649246243     PISSN: 15734048     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340410792007082     Document Type: Article

References (50)

1. Edwards RG, Fishel SB, Cohen J, et al. Factors influencingthe success of in vitro fertilization for alleviating human infertility. J In Vitro Fert Embryo Transf 1984; 1: 3-23.
2. Cummins JM, Breen TM, Harrison KL, Shaw JM, Wilson LM, Hennessey JF. A formula for scoring human embryo growth ratesin in vitro fertilization: its value in predicting pregnancy and incomparison with visual estimates of embryo quality. J In Vitro FertEmbryo Transf 1986; 3: 284-95.
3. Van Royen E, Mangelschots K, De Neubourg D, et al. Characteri-zation of a top quality embryo, a step towards single-embryo trans-fer. Hum Reprod 1999; 14: 2345-9.
4. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome:towards a single blastocyst transfer. Fertil Steril 2000; 73: 1155-8.
5. Sakkas D, Gardner DK. Evaluation of embryo quality: newstrategies to facilitate single embryo transfer. DK Gardner, AWeissman, CM Howles, Z. Shoham Eds. Textbook of AssistedReproductive Technologies: Laboratory and clinical perspectives. 3rd ed. Informa Healthcare, London, UK. 2009; pp. 241-54.
6. Leese HJ. Metabolism of the preimplantation mammalian embryo. Oxf Rev Reprod Biol 1991; 13: 35-72.
7. Conaghan J, Hardy K, Handyside AH, Winston RM, Leese HJ. Selection criteria for human embryo transfer: a comparison ofpyruvate uptake and morphology. J Assist Reprod Genet 1993; 10:21-30.
8. Gott AL, Hardy K, Winston RM, Leese HJ. Non-invasive meas-urement of pyruvate and glucose uptake and lactate production bysingle human preimplantation embryos. Hum Reprod 1990; 5: 104-8.
9. Gardner DK, Pool TB, Lane M. Embryo nutrition and energy me-tabolism and its relationship to embryo growth, differentiation, andviability. Semin Reprod Med 2000; 18: 205-18.
10. Gardner DK, Schoolcraft WB, Wagley L, Schlenker T, Stevens J, Hesla J. A prospective randomized trial of blastocyst cultureand transfer in in-vitro fertilization. Hum Reprod 1998; 13: 3434-40.
11. Gardner DK, Balaban B. Choosing between day 3 and day 5embryo transfers. Clin Obstet Gynecol 2006; 49: 85-92.
12. Katz-Jaffe MG, Schoolcraft WB, Gardner DK. Analysis of proteinexpression (secretome) by human and mouse preimplantationembryos. Fertil Steril 2006; 86: 678-85.
13. Brison DR, Hollywood K, Arnesen R, Goodacre R. Predictinghuman embryo viability: the road to non-invasive analysis of thesecretome using metabolic footprinting. Reprod Biomed Online 2007; 15: 296-302.
14. Kitteringham NR, Jenkins RE, Lane CS, Elliott VL, Park BK. Multiple reaction monitoring for quantitative biomarker analysis inproteomics and metabolomics. J Chromatogr B Analyt TechnolBiomed Life Sci 2009; 877: 1229-39.
15. Fiehn O. Metabolomics--the link between genotypes and pheno-types. Plant Mol Biol 2002; 48: 155-71.
16. Hollywood K, Brison DR, Goodacre R. Metabolomics: currenttechnologies and future trends. Proteomics 2006; 6:4716-23.
17. Deepinder F, Chowdary HT, Agarwal A. Role of metabolomicanalysis of biomarkers in the management of male infertility. Expert Rev Mol Diagn 2007; 7: 351-58.
18. Kendall C, Isabelle M, Bazant-Hegemark F, et al. Vibrationalspectroscopy: a clinical tool for cancer diagnostics. Analyst 2009;134: 1029-45.
19. Shai RM. Microarray tools for deciphering complex diseases. FrontBiosci 2006; 11: 1414-24.
20. Camp RL, Neumeister V, Rimm DL. A decade of tissue microar-rays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol 2008; 26: 5630-7.
21. Roessner U, Patterson JH, Forbes MG, Fincher GB, Langridge P, Bacic A. An investigation of boron toxicity in barley usingmetabolomics. Plant Physiol 2006; 142: 1087-101.
22. Kim YS, Maruvada P, Milner JA. Metabolomics in biomarkerdiscovery: future uses for cancer prevention. Future Oncol 2008; 4:93-102.
23. Chung YL, Griffiths JR. Using metabolomics to monitor anticancerdrugs. Ernst Schering Found Symp Proc 2007: 55-78.
24. Wishart DS, Knox C, Guo AC, et al. HMDB: a knowledgebasefor the human metabolome. Nucleic Acids Res 2009; 37: D603-10.
25. Frolkis A, Knox C, Lim E, et al. SMPDB: The Small MoleculePathway Database. Nucleic Acids Res 2010;38(Databaseissue): D480-7.
26. Canelas AB, ten Pierick A, Ras C, et al. Quantitative evaluation ofintracellular metabolite extraction techniques for yeast metabolom-ics. Anal Chem 2009; 81: 7379-89.
27. Goto T, Holding C, Daniels R, Salpekar A, Monk M. Gene expres-sion studies on human primordial germ cells and preimplantationembryos. Ital J Anat Embryol 2001; 106: 119-27.
28. Zhang P, Zucchelli M, Bruce S, et al. Transcriptome profilingof human pre-implantation development. PLoS One 2009; 4:e7844.
29. Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P. Follicular fluid content and oocyte quality: from singlebiochemical markers to metabolomics. Reprod Biol Endocrinol 2009; 7: 40.
30. Botros L, Sakkas D, Seli E. Metabolomics and its application fornon-invasive embryo assessment in IVF. Mol Hum Reprod 2008;14: 679-90.
31. Leese HJ, Barton AM. Pyruvate and glucose uptake by mouseova and preimplantation embryos. J Reprod Fertil 1984; 72: 9-13.
32. Gardner DK, Leese HJ. Assessment of embryo metabolism andviability. In: Trounson A, Gardner DK, Eds, Handbook of In VitroFertilization Boca Raton: CRC Press; 1999: pp. 347-72.
33. Gardner DK. Noninvasive metabolic assessment of single cells. Methods Mol Med 2007; 132: 1-9.
34. Gardner DK, Lane M, Stevens J, Schoolcraft WB. Noninvasiveassessment of human embryo nutrient consumption as a measure ofdevelopmental potential. Fertil Steril 2001; 76: 1175-80.
35. Gardner DK, Leese HJ. Assessment of embryo viability prior totransfer by the noninvasive measurement of glucose uptake. J ExpZool 1987; 242: 103-5.
36. Lane M, Gardner DK. Selection of viable mouse blastocysts priorto transfer using a metabolic criterion. Hum Reprod 1996; 11:1975-8.
37. Barnett DK, Bavister BD. What is the relationship between themetabolism of preimplantation embryos and their developmentalcompetence? Mol Reprod Dev 1996; 43: 105-33.
38. Katz-Jaffe MG, McReynolds S, Gardner DK, Schoolcraft WB. Therole of proteomics in defining the human embryonic secretome. Mol Hum Reprod 2009; 15: 271-7.
39. Dominguez F, Pellicer A, Simon C. The human embryo proteome. Reprod Sci 2009; 16: 188-90.
40. Singh R, Sinclair KD. Metabolomics: approaches to assessingoocyte and embryo quality. Theriogenology 2007; 68(Suppl 1):S56-62.
41. Houghton FD, Hawkhead JA, Humpherson PG, et al. J. Non-invasive amino acid turnover predicts human embryo developmen-tal capacity. Hum Reprod 2002; 17: 999-1005.
42. Brison DR, Houghton FD, Falconer D, et al. Identification ofviable embryos in IVF by non-invasive measurement of amino acidturnover. Hum Reprod 2004; 19: 2319-24.
43. Stokes PJ, Hawkhead JA, Fawthrop RK, et al. Metabolism ofhuman embryos following cryopreservation: implications for thesafety and selection of embryos for transfer in clinical IVF. HumReprod 2007; 22: 829-35.
44. Gardner DK, Wale PL, Collins R, Lane M. Viable humanblastocyts exhibit a different amino acid utilization profilethan those which fail to implant. Hum Reprod 2009; 24: 146(O-115).
45. Seli E, Sakkas D, Scott R, Kwok SC, Rosendahl SM, Burns DH. Noninvasive metabolomic profiling of embryo culture media usingRaman and near-infrared spectroscopy correlates with reproductivepotential of embryos in women undergoing in vitro fertilization. Fertil Steril 2007; 88: 1350-7.
46. Vergouw CG, Botros LL, Roos P, et al. Metabolomic profiling bynear-infrared spectroscopy as a tool to assess embryo viability: anovel, non-invasive method for embryo selection. Hum Reprod 2008; 23: 1499-504.
47. Scott R, Seli E, Miller K, Sakkas D, Scott K, Burns DH. Noninva-sive metabolomic profiling of human embryo culture media usingRaman spectroscopy predicts embryonic reproductive potential: aprospective blinded pilot study. Fertil Steril 2008; 90: 77-83.
48. Seli E, Botros L, Sakkas D, Burns DH. Noninvasive metabolomicprofiling of embryo culture media using proton nuclear magneticresonance correlates with reproductive potential of embryos inwomen undergoing in vitro fertilization. Fertil Steril 2008; 90:2183-9.
49. Ellis DI, Goodacre R. Metabolic fingerprinting in disease diagno-sis: biomedical applications of infrared and Raman spectroscopy. Analyst 2006; 131: 875-85.
50. Urbanski JP, Johnson MT, Craig DD, Potter DL, Gardner DK, Thorsen T. Noninvasive metabolic profiling using microfluidics foranalysis of single preimplantation embryos. Anal Chem 2008; 80:6500-7.